FindTrial
Sign In

Research on the Role of Multi-Sequence MR Imaging in Quantitatively Assessing the Stromal Ratio and Primary Stromal Types within Breast Cancer Tumors

Research on the Role of Multi-Sequence MR Imaging in Quantitatively Assessing the Stromal Ratio and Primary Stromal Types within Breast Cancer Tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101142
Enrollment
Unknown
Registered
2025-04-21
Start date
2025-04-21
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Pathologically confirmed as invasive breast cancer (not otherwise specified):None

Sponsors

People's Hospital of Zhenhai
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Pathologically confirmed as invasive breast cancer (not otherwise specified), with a lesion size exceeding 5mm, and having undergone an MRI examination within one week prior to surgery.

Exclusion criteria

Exclusion criteria: 1.Individuals with contraindications for MRI examination, those presenting with non-mass breast cancer, those who have undergone chemotherapy, radiotherapy, or immunotherapy prior to surgery, and those for whom diagnosis is not possible due to poor image quality.

Design outcomes

Primary

MeasureTime frame
Morphological features;T2WI sequence signal features;ADC values of diffuse sequences;Enhancement features;—

Countries

China

Contacts

Public ContactBei Xuwen

Ningbo Zhenhai District People's Hospital

79898640@qq.com+86 13857897064

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026